Trumps AntiWeaponization Fund Faces Opposition from Nearly Half of MAGA Supporters Poll Shows Snowflake Shares Surge 36 After Earnings Beat and 6 Billion Amazon Cloud Commitment Agnico Eagle Mines Announces 24 Billion Hope Bay Mine Redevelopment Amid Strong Earnings Momentum EU Imposes 230 Million Fine on Temu for Illegal Product Sales Southern Copper Corporation SCCO Draws Mixed Analyst Views Amid Commodity Supercycle Speculation China Urges APEC Cooperation as Commerce Minister Skips Meeting Over Urgent Official Business AIFF Q3 1998 Earnings EPS Plunges to 1290 Missing Estimates by 483 PRF Technologies PRFX Q2 2024 Earnings Deep EPS Miss as Operating Losses Widen CUZ Q1 2026 Earnings EPS Beat Highlights Operational Resilience WGRX Q1 2026 Earnings Negative EPS and No Revenue Reported Stock Plunges 22 ATOS Q1 2026 Earnings Loss Narrows Significantly Beating Estimates by 82 ConAgra Brands CAG Q1 2026 Earnings EPS Misses Estimates Amid Mixed Consumer Demand NewHold Investment Corp III NHIC Holds Steady Near Resistance SPAC Trading in Tight Range Crane Company CR Gains 15 as Shares Approach Key Resistance Levels Carlisle Companies CSL Edges Higher Holding Near Key Support A SPAC III Acquisition Corp Unit ASPCU Rises 378 as Momentum Builds Toward Key Resistance ADAMH Steady Near Par Adamas Senior Notes Hold Ground Amid Low Volatility Piper Sandler Warns Strait of Hormuz Closure Could Drive Oil to New Highs This Summer QuidelOrtho Q1 2026 Earnings EPS Misses Estimates Sharply Stock Declines 428 Biofrontera Inc BFRI Edges Higher A SmallCap Biotech Finds Temporary Footing XMAX Inc XWIN Holds Steady at 824 as Traders Eye Key Levels ADAMH Senior Notes Edge Lower Income Focus Amid Narrow Trading Range Reservoir Media Inc RSVR Holds Steady at 1020 as Market Awaits Catalysts Destiny Tech100 DXYZ Slides 68 as Support Level Beckons Yorkville Acquisition Corp Warrant MCGAW Holds Steady at 036 as Investors Eye Key Support Zone Aimei Health Technology Rights AFJKR Consolidates at 029 Amid Low Volatility Jupiter Neurosciences Jumps 135 as Speculative Interest Builds in SmallCap Biotech